IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q2 2017 Holdings

Filed 2017-08-07 | 4 holdings | $71.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cara Therapeutics Inc(CARAEUR)COM140755109$54.9K3,568,05776.7%
Mersana Therapeutics IncCOM59045L106$11.4K818,03316.0%
Inotek Pharmaceuticals CorpCOM45780V102$5.0K2,627,7907.0%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$287159,6010.4%